MODE OF ACTION OF IRON(III) CHELATORS AS ANTIMALARIALS .3. OVERADDITIVE EFFECTS IN THE COMBINED ACTION OF HYDROXAMATE-BASED AGENTS ON IN-VITRO GROWTH OF PLASMODIUM-FALCIPARUM
A. Tsafack et al., MODE OF ACTION OF IRON(III) CHELATORS AS ANTIMALARIALS .3. OVERADDITIVE EFFECTS IN THE COMBINED ACTION OF HYDROXAMATE-BASED AGENTS ON IN-VITRO GROWTH OF PLASMODIUM-FALCIPARUM, Molecular pharmacology, 47(2), 1995, pp. 403-409
Hydroxamate-based iron(lll) chelators exhibit potent antimalarial effe
cts on the asexual stages of Plasmodium falciparum grown in vitro. Ant
imalarial activity varies with the parasite growth stage and the drug
permeation properties. The hydrophilic drug desferrioxamine (DFO) is i
neffective on early stages (ring forms) of the parasite due to its poo
r permeability but irreversibly blocks the growth of advanced stages o
f parasites. On the other hand, hydrophobic reversed siderophores (RSF
s) are more membrane permeable and affect all parasite developmental s
tages; they affect ring forms irreversibly and trophozoite/schizont fo
rms reversibly and at relatively faster rates, compared with DFO. Thes
e observations have provided the basis for postulating a possible over
additive action of the two, distinctly acting, iron chelator types for
enhanced antimalarial activity. This was assessed in this study by us
ing novel fast-acting chelators such as RSF derivatives (RSFleum2 and
RSFm2) in combination with the relatively slow-acting DFO. Parasite gr
owth was assessed in terms of nucleic acid synthesis and parasitemia.
The results indicate that, at any molar ratios of the two types of dru
gs, the combined inhibitory effect was faster and more potent than the
sum of individual effects. The combined drug action showed neither ad
ditive nor independent but overadditive properties, as well as sustain
ed inhibition even after drug removal. The potentiating action of RSFs
on the long-lasting effects of DFO on parasite growth conformed with
the postulated mechanistic model of iron chelator action and iron hand
ling by parasites. Iron chelator combinations might be of therapeutic
value.